Endocrinology, Vol 137, 794-797, Copyright © 1996 by Endocrine Society

ARTICLES

The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development

RW Brown, R Diaz, AC Robson, YV Kotelevtsev, JJ Mullins, MH Kaufman and JR Seckl
University Department of Medicine, Centre for Genome Research, Edinburgh.

Glucocorticoids play important roles in development and 'fetal programming'. Fetal exposure to excess glucocorticoids reduces birth weight and causes later hypertension. To investigate these processes further we have determined the detailed category of 11 beta- hydroxysteroid dehydrogenase type2 (11 beta-HSD2, which potently inactivates glucocorticoids) and the mineralocorticoid receptor (MR) by in situ hybridisation from embryonic day 9.5 (E9.5, term = E19) until after birth in the mouse. Widespread abundant 11 beta-HSD2 mRNA expression from E9.5-E12.5 changes dramatically at approximately E13 to a limited tissue-specific pattern (kidney, hindgut, testis/bile ducts, lung and a few brain regions (later seen in cerebellum, thalamus, roof of midbrain, neuroepithelial regions in pons and near the subicular hippocampus)). Placenta (labyrinthine zone) and extra-embryonic membranes express abundant 11 beta-HSD2 mRNA until E15.5 but this ceases = E16.5. It is unclear to what extent rodent term placental 11 beta-HSD activity is due to persisting 11 beta-HSD2 protein. Convincing MR mRNA expression is seen from E13.5 and includes pituitary, heart, muscle and meninges with expression later in gut, kidney, thymus, discrete areas of lung and several brain regions (including hippocampus, rhinencephalon and hypothalamus). 11 beta-HSD2 and MR clearly co-localise = E18.5 in kidney and colon and might do so in discrete areas of lung (E14-15) and neuroepithelia near the subicular hippocampus. Probably elsewhere MR are non-selective and 11 beta-HSD2 is involved in protecting glucocorticoid receptors in fetal fetal tissues. Comparison with previous enzymology studies suggest the changing pattern of 11 beta-HSD2 mRNA is likely to be translated into enzyme activity and have significant parallels in human development.

This article has been cited by other articles:

				A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, June 13, 2008; (2008) dmn021v1. [Abstract] [Full Text] [PDF]

				J. C. Geerling and A. D. Loewy 11beta-Hydroxysteroid dehydrogenase 2 vs. transgene: discrepant loci of expression in the adult brain Am J Physiol Renal Physiol, July 1, 2007; 293(1): F440 - F441. [Full Text] [PDF]

				A. Naray-Fejes-Toth and G. Fejes-Toth Reply to Geerling and Loewy Am J Physiol Renal Physiol, July 1, 2007; 293(1): F442 - F443. [Full Text] [PDF]

				A. Naray-Fejes-Toth and G. Fejes-Toth Novel mouse strain with Cre recombinase in 11beta-hydroxysteroid dehydrogenase-2-expressing cells Am J Physiol Renal Physiol, January 1, 2007; 292(1): F486 - F494. [Abstract] [Full Text] [PDF]

				S. A. Reini, C. E. Wood, E. Jensen, and M. Keller-Wood Increased maternal cortisol in late-gestation ewes decreases fetal cardiac expression of 11beta-HSD2 mRNA and the ratio of AT1 to AT2 receptor mRNA Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1708 - R1716. [Abstract] [Full Text] [PDF]

				M. C. Holmes, C. T. Abrahamsen, K. L. French, J. M. Paterson, J. J. Mullins, and J. R. Seckl The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J. Neurosci., April 5, 2006; 26(14): 3840 - 3844. [Abstract] [Full Text] [PDF]

				M. Keller-Wood, M. J. Powers, J. A. Gersting, N. Ali, and C. E. Wood Genomic analysis of neuroendocrine development of fetal brain-pituitary-adrenal axis in late gestation Physiol Genomics, February 23, 2006; 24(3): 218 - 224. [Abstract] [Full Text] [PDF]

				J. M. Paterson, J. R. Seckl, and J. J. Mullins Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R642 - R652. [Abstract] [Full Text] [PDF]

				P. R. Provost and Y. Tremblay Genes Involved in the Adrenal Pathway of Glucocorticoid Synthesis Are Transiently Expressed in the Developing Lung Endocrinology, May 1, 2005; 146(5): 2239 - 2245. [Abstract] [Full Text] [PDF]

				M. Keller-Wood, C. E. Wood, Y. Hua, and D. Zhang Mineralocorticoid Receptor Expression in Late-Gestation Ovine Fetal Lung Reproductive Sciences, February 1, 2005; 12(2): 84 - 91. [Abstract] [PDF]

				T. P. Fleming, W. Y. Kwong, R. Porter, E. Ursell, I. Fesenko, A. Wilkins, D. J. Miller, A. J. Watkins, and J. J. Eckert The Embryo and Its Future Biol Reprod, October 1, 2004; 71(4): 1046 - 1054. [Abstract] [Full Text] [PDF]

				I. Bossis, S. Nishimura, M. Muchow, and T. E. Porter Pituitary Expression of Type I and Type II Glucocorticoid Receptors during Chicken Embryonic Development and Their Involvement in Growth Hormone Cell Differentiation Endocrinology, July 1, 2004; 145(7): 3523 - 3531. [Abstract] [Full Text] [PDF]

				L. B. Sher, H. W. Woitge, D. J. Adams, G. A. Gronowicz, Z. Krozowski, J. R. Harrison, and B. E. Kream Transgenic Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Osteoblasts Reveals an Anabolic Role for Endogenous Glucocorticoids in Bone Endocrinology, February 1, 2004; 145(2): 922 - 929. [Abstract] [Full Text] [PDF]

				J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text]

				K. Holemans, L. Aerts, and F. A. Van Assche Fetal Growth Restriction and Consequences for the Offspring in Animal Models Reproductive Sciences, October 1, 2003; 10(7): 392 - 399. [Abstract] [PDF]

				E. P. Gomez-Sanchez, V. Ganjam, Y. J. Chen, Y. Liu, M. Y. Zhou, C. Toroslu, D. G. Romero, M. D. Hughson, A. de Rodriguez, and C. E. Gomez-Sanchez Regulation of 11{beta}-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E272 - E279. [Abstract] [Full Text] [PDF]

				M. A. Miller, S. J. Kottler, J. A. Ramos-Vara, P. J. Johnson, V. K. Ganjam, and T. J. Evans 3-Methylindole Induces Transient Olfactory Mucosal Injuryin Ponies Vet. Pathol., July 1, 2003; 40(4): 363 - 370. [Abstract] [Full Text] [PDF]

				J. S. Wilcoxon, J. Schwartz, F. Aird, and E. E. Redei Sexually dimorphic effects of maternal alcohol intake and adrenalectomy on left ventricular hypertrophy in rat offspring Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E31 - E39. [Abstract] [Full Text] [PDF]

				A. Thompson, V.K.M. Han, and K. Yang Spatial and Temporal Patterns of Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 Messenger RNA and Glucocorticoid Receptor Protein in the Murine Placenta and Uterus During Late Pregnancy Biol Reprod, December 1, 2002; 67(6): 1708 - 1718. [Abstract] [Full Text] [PDF]

				K. Nakamura, J. B. Stokes, and P. B. McCray Jr. Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lung Am J Physiol Cell Physiol, September 1, 2002; 283(3): C762 - C772. [Abstract] [Full Text] [PDF]

				C. L. McTernan, N. Draper, H. Nicholson, S. M. Chalder, P. Driver, M. Hewison, M. D. Kilby, and P. M. Stewart Reduced Placental 11{beta}-Hydroxysteroid Dehydrogenase Type 2 mRNA Levels in Human Pregnancies Complicated by Intrauterine Growth Restriction: An Analysis of Possible Mechanisms J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4979 - 4983. [Abstract] [Full Text] [PDF]

				B. Blondeau, J. Lesage, P. Czernichow, J. P. Dupouy, and B. Breant Glucocorticoids impair fetal {beta}-cell development in rats Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E592 - E599. [Abstract] [Full Text] [PDF]

				P.M. Driver, M.D. Kilby, I. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart Expression of 11{beta}-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies Mol. Hum. Reprod., April 1, 2001; 7(4): 357 - 363. [Abstract] [Full Text] [PDF]

				D. Le Menuet, S. Viengchareun, P. Penfornis, F. Walker, M.-C. Zennaro, and M. Lombes Targeted Oncogenesis Reveals a Distinct Tissue-specific Utilization of Alternative Promoters of the Human Mineralocorticoid Receptor Gene in Transgenic Mice J. Biol. Chem., March 10, 2000; 275(11): 7878 - 7886. [Abstract] [Full Text] [PDF]

				I. C. McMillen, K. E. Warnes, M. B. Adams, J. S. Robinson, J. A. Owens, and C. L. Coulter Impact of Restriction of Placental and Fetal Growth on Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 and Type 2 Messenger Ribonucleic Acid in the Liver, Kidney, and Adrenal of the Sheep Fetus Endocrinology, February 1, 2000; 141(2): 539 - 543. [Abstract] [Full Text] [PDF]

				R. Schmitt, D. H. Ellison, N. Farman, B. C. Rossier, R. F. Reilly, W. B. Reeves, I. Oberbaumer, R. Tapp, and S. Bachmann Developmental expression of sodium entry pathways in rat nephron Am J Physiol Renal Physiol, March 1, 1999; 276(3): F367 - F381. [Abstract] [Full Text] [PDF]

				S. Watanabe, K. Matsushita, P. B. McCray Jr., and J. B. Stokes Developmental expression of the epithelial Na+ channel in kidney and uroepithelia Am J Physiol Renal Physiol, February 1, 1999; 276(2): F304 - F314. [Abstract] [Full Text] [PDF]

				P. J. Burton and B. J. Waddell Dual Function of 11ß-Hydroxysteroid Dehydrogenase in Placenta: Modulating Placental Glucocorticoid Passage and Local Steroid Action Biol Reprod, February 1, 1999; 60(2): 234 - 240. [Abstract] [Full Text] [PDF]

				C. Wotus, B. K. Levay-Young, L. M. Rogers, C. E. Gomez-Sanchez, and W. C. Engeland Development of Adrenal Zonation in Fetal Rats Defined by Expression of Aldosterone Synthase and 11{beta}-Hydroxylase Endocrinology, October 1, 1998; 139(10): 4397 - 4403. [Abstract] [Full Text] [PDF]

				Y. Kotelevtsev, M. C. Holmes, A. Burchell, P. M. Houston, D. Schmoll, P. Jamieson, R. Best, R. Brown, C. R. W. Edwards, J. R. Seckl, et al. 11beta -Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress PNAS, December 23, 1997; 94(26): 14924 - 14929. [Abstract] [Full Text] [PDF]

				G. Hirasawa, H. Sasano, K.-i. Takahashi, K. Fukushima, T. Suzuki, N. Hiwatashi, T. Toyota, Z. S. Krozowski, and H. Nagura Colocalization of 11{beta}-Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Epithelia J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3859 - 3863. [Abstract] [Full Text] [PDF]

				P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text]

				R. E. Smith, K. X. Z. Li, R. K. Andrews, and Z. Krozowski Immunohistochemical and Molecular Characterization of the Rat 11{beta}-Hydroxysteroid Dehydrogenase Type II Enzyme Endocrinology, February 1, 1997; 138(2): 540 - 547. [Abstract] [Full Text] [PDF]